Longeveron Inc. Profile Avatar - Palmy Investing

Longeveron Inc.

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture…

Biotechnology
US, Miami [HQ]

News

Theses · Events · Sentiments
End of LGVN's Analysis
CIK: 1721484 CUSIP: 54303L104 ISIN: US54303L1044 LEI: - UEI: -
Secondary Listings
LGVN has no secondary listings inside our databases.